Net Income (Quarterly) Chart

Historical Net Income (Quarterly) Data

View and export this data back to 1984. Upgrade now.
Date Value
September 30, 2024 2.694B
June 30, 2024 4.686B
March 31, 2024 3.255B
December 31, 2023 4.049B
September 30, 2023 26.03B
June 30, 2023 5.144B
March 31, 2023 -68.00M
December 31, 2022 3.52B
September 30, 2022 4.458B
June 30, 2022 4.814B
March 31, 2022 5.149B
December 31, 2021 4.736B
September 30, 2021 3.667B
June 30, 2021 6.278B
March 31, 2021 6.197B
December 31, 2020 1.738B
September 30, 2020 3.554B
June 30, 2020 3.626B
March 31, 2020 5.796B
December 31, 2019 4.01B
September 30, 2019 1.753B
June 30, 2019 5.607B
March 31, 2019 3.749B
December 31, 2018 3.042B
September 30, 2018 3.934B
Date Value
June 30, 2018 3.954B
March 31, 2018 4.367B
December 31, 2017 -10.71B
September 30, 2017 3.764B
June 30, 2017 3.827B
March 31, 2017 4.422B
December 31, 2016 3.814B
September 30, 2016 4.272B
June 30, 2016 3.997B
March 31, 2016 4.457B
December 31, 2015 3.215B
September 30, 2015 3.358B
June 30, 2015 4.516B
March 31, 2015 4.32B
December 31, 2014 2.521B
September 30, 2014 4.749B
June 30, 2014 4.326B
March 31, 2014 4.727B
December 31, 2013 3.519B
September 30, 2013 2.982B
June 30, 2013 3.833B
March 31, 2013 3.497B
December 31, 2012 2.567B
September 30, 2012 2.968B
June 30, 2012 1.408B

Net Income Definition

Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.

Read full definition.

Net Income (Quarterly) Range, Past 5 Years

-68.00M
Minimum
Mar 2023
26.03B
Maximum
Sep 2023
5.167B
Average
4.254B
Median

Net Income (Quarterly) Benchmarks

Amgen Inc 2.83B
Eli Lilly and Co 970.30M
Merck & Co Inc 3.157B
Pfizer Inc 4.465B
AbbVie Inc 1.561B